Current Report Filing (8-k)
15 October 2014 - 1:43AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): October 13, 2014
(Exact Name of Registrant as Specified
in its Charter)
Nevada |
|
000-54770 |
|
45-0704149 |
(State or Other
Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
2544 Tarpley Road Suite 12, Carrollton, TX 75006 |
(Address of Principal Executive Office) (Zip Code) |
Registrant's telephone number, including
area code: 214-666-8364
____________________________________
(former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2 below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 Other Events.
Previously, on September 18, 2014, Med-Cannabis Pharma,
Inc. (the “Company”) announced it was in the process of opening a store in Pierce County, Washington. The Company has
determined that, based upon the continually changing rules and regulations in the State of Washington concerning medical marijuana,
that it is not in the best interests of the Company to commence operations in Washington.
The Company is engaged in discussions concerning managing
a medical dispensary in Oregon and hopes to commence operations there if the due diligence for this business is successful.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
October 13, 2014 |
MED-CANNABIS PHARMA, INC. |
|
|
|
/s/ Graciela Moreno |
|
|
|
Graciela Moreno, CEO |
|
|
Pegasus Companies (CE) (USOTC:PEGX)
Historical Stock Chart
From May 2024 to Jun 2024
Pegasus Companies (CE) (USOTC:PEGX)
Historical Stock Chart
From Jun 2023 to Jun 2024